Ex vivo expanded multi-antigen specific lymphocytes for the treatment of solid tumors.

3042Background: Patients with solid tumors refractory to standard therapies have poor prognoses, and most salvage therapies are toxic and ineffective. Antigen-specific T cell therapies offer a prom...